Condition: HIV Infections · ART · Noncompliance, Patient · Sponsor: University of Missouri-Columbia
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.
This description comes directly from the study's public registry record.
Dima Dandachi, MD, MPH · (573) 882-7746 · dandachid@health.missouri.edu
Hilal Abdessamad, MD · 5735303333 · hilal.abdessamad@health.missouri.edu
Always discuss trial participation with your own doctor first.
| University of Missouri-Columbia | Columbia, Missouri, United States | Recruiting |
| KC Care Health Center | Kansas City, Missouri, United States | Recruiting |
| AIDS Project of the Ozarks | Springfield, Missouri, United States | Recruiting |
| NOVUS Health | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06374758